Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Rectal Neoplasms × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Interventional 32 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3 Glioblastoma 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Radiation Injuries 1 Ototoxicity 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphatic Metastasis 1 Locally Advanced Cervical Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hearing Loss 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Cognitive Dysfunction 1 Cholangiocarcinoma 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Surveys and Questionnaires 9 Proctectomy 8 Capecitabine 8 Surgical Procedures, Operative 7 Radiotherapy 5 Oxaliplatin 5 Neoadjuvant Therapy 5 Psychiatric Rehabilitation 4 Blood Specimen Collection 4 Amplified Fragment Length Polymorphism Analysis 4 Robotic Surgical Procedures 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Immunohistochemistry 3 Endoscopic Mucosal Resection 3 Biopsy 3 tislelizumab 2 Ultrasonography 2 Transanal Endoscopic Surgery 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Observation 2 Mental Status and Dementia Tests 2 Laparoscopy 2 Interviews as Topic 2 Immunologic Techniques 2 Gene Expression Profiling 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 saxagliptin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233595 2019-08-13

Rectal PET/MRI

University of California, San Francisco

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡